These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23308079)

  • 1. The immune response to human CMV.
    La Rosa C; Diamond DJ
    Future Virol; 2012 Mar; 7(3):279-293. PubMed ID: 23308079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell therapy of human CMV and EBV infection in immunocompromised hosts.
    Riddell SR; Greenberg PD
    Rev Med Virol; 1997 Sep; 7(3):181-192. PubMed ID: 10398482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of cytomegalovirus infection in immunocompetent individuals.
    Kano Y; Shiohara T
    J Dermatol Sci; 2000 Apr; 22(3):196-204. PubMed ID: 10698156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.
    Lemmermann NA; Fink A; Podlech J; Ebert S; Wilhelmi V; Böhm V; Holtappels R; Reddehase MJ
    Med Microbiol Immunol; 2012 Nov; 201(4):497-512. PubMed ID: 22961127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Genetics of Cytomegalovirus Pathogenesis.
    Sezgin E; An P; Winkler CA
    Front Genet; 2019; 10():616. PubMed ID: 31396258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness.
    Souquette A; Frere J; Smithey M; Sauce D; Thomas PG
    Geroscience; 2017 Jun; 39(3):293-303. PubMed ID: 28647907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation.
    Zdziarski P
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.
    Steffens HP; Kurz S; Holtappels R; Reddehase MJ
    J Virol; 1998 Mar; 72(3):1797-804. PubMed ID: 9499030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells.
    Mayer BT; Krantz EM; Swan D; Ferrenberg J; Simmons K; Selke S; Huang ML; Casper C; Corey L; Wald A; Schiffer JT; Gantt S
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence.
    Nikolich-Žugich J; van Lier RAW
    Geroscience; 2017 Jun; 39(3):245-249. PubMed ID: 28624867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological burden of human cytomegalovirus infection.
    Khan N
    Arch Immunol Ther Exp (Warsz); 2007; 55(5):299-308. PubMed ID: 18219760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.
    Khan N; Hislop A; Gudgeon N; Cobbold M; Khanna R; Nayak L; Rickinson AB; Moss PA
    J Immunol; 2004 Dec; 173(12):7481-9. PubMed ID: 15585874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus induced hepatitis in an immunocompetent host.
    Azad AK; Ahmed T; Chowdhury AJ; Rahim MA; Mahmud AK; Rahman MA
    Mymensingh Med J; 2008 Jul; 17(2 Suppl):S104-6. PubMed ID: 18946441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus CMV: an emerging animal model for human CMV.
    Powers C; Früh K
    Med Microbiol Immunol; 2008 Jun; 197(2):109-15. PubMed ID: 18193454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
    Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
    Gardner TJ; Tortorella D
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging.
    Nikolich-Žugich J; Čicin-Šain L; Collins-McMillen D; Jackson S; Oxenius A; Sinclair J; Snyder C; Wills M; Lemmermann N
    Geroscience; 2020 Apr; 42(2):495-504. PubMed ID: 32162210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.